Analysis of factors associated with the outcome of hospitalisation in patients with traumatic pelvic fracture combined with shock

分析创伤性骨盆骨折合并休克患者住院结局的相关因素

阅读:1

Abstract

OBJECTIVE: To examine the determinants of hospitalisation outcomes in patients with traumatic pelvic fractures accompanied by shock through the establishment of a retrospective cohort study. analyseanalyse the influencing factors of hospitalisation. METHODS: To examine the factors influencing the outcome of hospitalisation treatment for patients with traumatic pelvic fracture combined with shock, we retrospectively analysed the clinical data of 134 patients in our hospital from July 2021 to July 2024. We classified the patients into survival and death groups based on the outcome of hospitalisation, gathered and compared the pertinent data of the research subjects, and performed logistic regression analysis for the items with differences. We classified. RESULTS: The covariance analysis showed that there was no covariance among Glasgow Coma Score (GCS), Shock Index (SI), Mean Arterial Pressure (MAP), Blood Lactic Acid (Lac), and Fibrinogen (Fib) levels in 134 patients with traumatic pelvic fracture combined with shock, of whom 108 survived hospitalization (80.60%) and were included in the survival group, and 26 patients died (19.40%) and were included in the death group; Plotting the receiver operating curve (ROC) revealed that each of the factors above and the joint prediction of Area Under Curve (AUC) values were 0.689, 0.673, 0.832, 0.681, 0.670, and 0.930, respectively. The logistic regression equation also showed that GCS score, SI index, MAP, Lac, and Fib levels were all significant factors in the death of hospitalised patients with traumatic pelvic fracture combined with shock. CONCLUSION: GCS score, SI index, MAP, Lac and Fib levels are all influential factors in the hospitalization outcome of patients with traumatic pelvic fracture combined with shock, and their joint prediction accuracy is high, and the clinic can combine the above factors to strengthen the risk monitoring, and formulate the relevant program to improve the hospitalization outcome of patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。